Curaleaf (OTCMKTS:CURLF) Earns Buy Rating from MKM Partners

Curaleaf (OTCMKTS:CURLFGet Rating)‘s stock had its “buy” rating reiterated by stock analysts at MKM Partners in a note issued to investors on Tuesday, TipRanks reports. They currently have a $14.00 price objective on the stock. MKM Partners’ price objective suggests a potential upside of 149.55% from the company’s current price.

A number of other brokerages have also issued reports on CURLF. Needham & Company LLC cut their price target on shares of Curaleaf from $17.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, March 4th. Stifel Nicolaus dropped their target price on shares of Curaleaf from C$31.00 to C$25.00 in a research report on Monday, March 7th. Benchmark assumed coverage on shares of Curaleaf in a research report on Friday, February 25th. They issued a “buy” rating and a $12.00 target price for the company. Finally, Cantor Fitzgerald raised their target price on shares of Curaleaf from $15.50 to $16.50 and gave the stock an “overweight” rating in a research report on Monday, April 25th. Two equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from, the company has a consensus rating of “Buy” and a consensus price target of $19.15.

Curaleaf stock traded down $0.34 during trading hours on Tuesday, reaching $5.61. The stock had a trading volume of 489,728 shares, compared to its average volume of 660,853. Curaleaf has a 52 week low of $5.14 and a 52 week high of $15.47. The company has a fifty day simple moving average of $6.37 and a 200-day simple moving average of $7.92.

Curaleaf (OTCMKTS:CURLFGet Rating) last announced its quarterly earnings results on Thursday, March 3rd. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02).

Curaleaf Company Profile (Get Rating)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements.

Featured Stories

Analyst Recommendations for Curaleaf (OTCMKTS:CURLF)

Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with's FREE daily email newsletter.